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Conclusion: The MLS index is a new easy and practical method for assessment of mitral
stenosis severity.
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Mitral Balloon Valvuloplasty Long-term Follow-up Of Single Balloon Versus Inoue
Balloon Techniques. Independent Predictors Of Survival And Event Free Survival
Edison Carvalho Sandoval Peixoto,1 Ivana Picone Borges,2
Rodrigo Trajano Sandoval Peixoto,3 Ricardo Trajano Sandoval Peixoto4
1Fluminense Federal University, Niteroi, Brazil 2Military Police of Rio de Janeiro, Rio
de Janeiro, Brazil 3National Institute of Cardiology, Rio de Janeiro, Brazil 4State
Institute of Cardiology, Rio de Janeiro, Brazil
Objectives: The single balloon (SB), that is the less expensive technique to perform
mitral balloon (MBV) valvuloplasty. This study aimed to demonstrate that MBV with SB
Balt has similar outcome and long-term follow-up (FU) than MBV performed with the
Inoue worldwide accepted technique.
Methods: From 1987 to 12/31/2011 a total of 526 procedures were performed, being
312 procedures with a FU, 56 (17.9%) with Inoue balloon (IB), the IB group (IBG) and
256 (82.1%) SB Balt group (SBG). The mean FU in IBG was 3327 (2 to 118) and in
SBG 5533 (1 to 198) months (P0.0001). Univariate analysis and multivariate Cox
analysis were utilized to determine independent predict variables of survival and event free
survival (EFS) in both technique groups and major events were (death, cardiac surgery and
new MBV).
Results: In IBG and SBG there were: female 42 (75.0%) and 222 (86.7%) procedures,
(P0.0276), mean age 37.310.0 (19 to 63) and 38.012.6 (13 to 83) years (P0.7138),
sinus rhythm 51 (91.1%) and 215 (84.0%), (P0.1754), echo score (ES) 7.61.3 (5 to
10) and 7.21.5 (4 to 14) points (P0.0528), echo mitral valve area (MVA) pre-MBV
0.960.18 and 0.930.21 cm2 (P0,2265). Post-MBV mean MVA (Gorlin) were
2.000.52 and 2.020.37 cm2 (P0.9550) and at the end of the FU there were: echo
MVA 1.710.41 and 1.540.51 cm2 (P0.0552), new severe mitral regurgitation in 5
(8.9%) and 17 (6.6%) patients (P0.5633), new MBV in 1 (1.8%) and 13 (5,1%),
(P0.4779), mitral valve surgery in 3 (5.4%) and 27 (10.4%), (P0.3456), deaths 2
(3.6%) and 11 (4.3%) deaths, (P1.000), being cardiac deaths 1 (1.8%) and 9 (3.5%),
(p1.0000), major events 5 (8.9%) and 46 (18.0%), (P0.1449). In univariate analysis
and multivariate Cox analysis the SB or IB technique used do not predict survival or
EFS and independent risk factors to survival (multivariate Cox analysis with 2 models
with 5 and 6 variables) were: age50 years (P0.016, HR0.233, 95% IC 0.071-0.764),
ES8 (P0.001, HR0.105, 95% IC 0.34-0.327), MBV dilatation area (P0.001, HR
16.838, 95% IC 3.353-84.580) and mitral valve surgery in the FU (P0.001, HR0.152,
95% IC 0.050-0.459) and to EFS: prior commissurotomy (P0.012, HR0.390, 95%
IC 0.187-0.813) and post-MBV MVA 1.50 cm2 (P0.001, HR7.969, 95% IC
3.413-18.608).
Conclusions: MBV with SB and IB were equally efficient with similar survival and EFS
in the FU. Independent predictors of survival were: age 50 years, ES 8 points, MBV
dilatation area and mitral valve surgery in the FU and of event EFS: prior commissur-
otomy and post-MBV MVA 1.50 cm2.
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Major clinical Outcomes after Mitral Valve Repair in Low Risk Patients
Xiumei Sun, Jennifer Ellis, Louis T Kanda, Paul J Corso
MedStar Washington Hospital Center, Washington, DC
Background: To report the short-term clinical outcomes of patients with severe mitral
valve regurgitation undergoing mitral valve repair.
Methods: Four hundred forty patients who underwent mitral valve repair between 2003
to August 2012 in our Institution were identified by using a Society of thoracic Surgeon
(STS) standardized database. We excluded those patients who had previous coronary
artery bypass surgery or valve surgery or endocarditis from the study. The STS mortality
risk sore 3 was used as a cutoff point to define the study group.
Results: Three hundred fifty nine patients with STS mortality risk score lower than 3
were included in the analysis. Observed 30-day mortality and other major clinical
outcomes and predicted outcomes are presented in the following table.
Major Postoperative Clinical Outcomes after Mitral Valve Repair.
Observed
Outcomes
(N359)
STS
Predicted
Outcomes
Mortality (%) 2 (0.6) 0.6
Stroke (%) 4 (1.1) 1.0
Renal-failure (%) 1 (0.3) 2.0
Total ICU hours 43.265.7
Prolonged
ventilation (%)
21 (5.8) 5.7
LOS (days) 5.94.5
Postoperative atrial
ﬁbrillation (%)
100 (27.9)
Total PRBC (ml) 301.5581.8
Readmission to
hospital (%)
31 (8.6)
Moderate or Severe
postoperative
mitral valve
regurgitation (%)
4 (1.1)
STS Predicted
Morbidity or
Mortality (%)
10.8
Conclusions: Our single center experience of isolated mitral valve repair in patients with
STS mortality score lower than 3 is generally in concordance with the predicted STS
outcome rates. The postoperative mitral regurgitation was lower than reported rates in
published articles.
Other
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Follow-up Results And Health-related Quality-of-life After Implantation
Of Left Ventricular Passive Containment Device For Heart Failure And
Dilated Cardiomyopathy
Giuseppe Nasso, Raffaele Bonifazi, Vito Romano, Felice Piancone, Giuseppe Visicchio,
Giuseppe Speziale
Division of Cardiac Surgery, GVM Care & Research, Bari, Italy
Objective: We conducted a prospective study of the clinical outcomes and health-related
quality-of-life after implantation of the CorCap cardiac support device (Acorn Cardio-
vascular Inc.) for dilated cardiomyopathy.
Methods: The CorCap was implanted in case of dilated cardiomyopathy (left ventricular
end-diastolic diameter 60 mm. and 80 mm., left ventricular ejectionfraction 30%),
symptoms of heart failure (NYHA class III or IV) despite maximal medical therapy, and
good renal, pulmonary and hepatic functions. Echocardiographic follow-up and evalua-
tion with the SF-36 questionnaire were performed. An average 25.1 4.3 follow-up was
available.
Results: Forty patients were included. A statistically significant improvement was
evident in mean left ventricular ejection fraction, end-diastolic diameter, end-diastolic
volume and volume index, end systolic diameter, end-systolic volume and volume index,
left ventricular sphericity index at the last follow-up vs. baseline. The cumulative mortality
was 10% (no follow-up deaths after the 1st postoperative year). The average physical
health domain scores (physical functioning, role physical, general health) were statistically
improved. Average mental health domain scores were also increased. Concomitant mitral
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surgery and cardiac resynchronization therapy did not appear to significantly improve the
clinical results. Cox regression evidenced lesser improvement in quality-of-life domains
among patients with ischemic cardiomyopathy.
Conclusions: The cardiac support device obtains reverse remodelling of the left ventricle,
and allows stable improvement in the quality of life until to the 2nd year post-
implantation. The integration of different and complementary strategies (cardiac support
device, resynchronization therapy and aggressive treatment of functional mitral regurgi-
tation) may represent the key of success for the more complex patients.
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The Tri-dimensional Complete Ring: A Novel Device For More Efficient Tricuspid
Valve Repair. Initial Results
Wajih MAAZOUZI
Departement of Cardiovascular surgery- Ibn Sina Hospital, Rabat, Morocco
Background: The interest for the tricuspid valve increased significantly as well among
cardiologists as among surgeons. The reason is double: on one hand, the severe tricuspid
regurgitation occurring occasionally after isolated mitral valve replacement; on the other
hand, development of the three-dimensional echocardiography allowing a more pro-
nounced exploration of the tricuspid valve and right ventricle functions. Because
annuloplasty remains the gold standard technique in tricuspid surgery, our aim was to
evaluate the impact of our tri-dimensional complete ring in improving the short and long
term outcomes of this conservative surgery.
Methods: This is a prospective study including 30 patients (Mean age was 25 years). All
of them were operated on for rheumatic left sided valves disease associated with grade III
functional tricuspid regurgitation. Our new tri-dimensional complete ring was used for
tricuspid valve repair. The average time of implantation was five minutes. The complete
structure and the modulated flexibility of this new ring, exclusively made of PTFE and
well tolerated materiel as demonstrated by our experimental and histological studies, are
expected to respect and restore the physiology annulus, and finally lead the septal leaflet
to take part to the valvular coaptation.
Results: There was no hospital mortality and no major complications. Mean follow-up
was 12 months. No significant tricuspid regurgitation was observed either at discharge or
during follow up. Furthermore, 3D echocardiography showed a good remodeling of the
tricuspid annulus and a significant improvement of right ventricular function.
Conclusions: The tri-dimensional complete ring allows a more physiologic, cheaper and
faster repair of the tricuspid valve. Furthermore, our ring made exclusively from PTFE
seems to be rapidly endothelalized and more resistant to infection. Whereas short and mid
term results are good and promising, longer follow up is required to confirm these trends.
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Ductal Stenting In Neonates With Duct Dependant Circulation: The Genuine And
Feasible Option
Prabhat Kumar
Aditya Birla Hospital, Pune, India
Introduction: Duct dependant circulation in a neonate presents as a life threatening
emergency. These patients can survive only if duct patency is maintained for the time
before they are taken up for a planned staged surgery. Surgical palliative shunt, a surgical
option or ductal stenting, a catheter based intervention can be performed in such patients.
Objective: We performed ductal stenting in 8 babies with duct dependant circulation
with an objective to observe our results.
Patient and Methods: 8 babies with age ranging from 22 hours to 18 days underwent
ductal stenting (table 1). Procedure was performed under deep sedation. Venous and
arterial access was obtained by Scheldinger’s technique. Bare metal stents were used in all
patients. Mean procedure time was 48 minutes while fluoroscopy time was 14 minutes.
Table 1
No Age Sex Weight (kg) Diagnosis
Stent size
(mm)
1 22 hrs M 2.8 HLHS 8 28
2 3 days F 2.4 Tricuspid & Pulm atresia 3.75 18
3 3 days F 2.85 HLHS 7 30
4 2 days F 2.35 HLHS 8 24
5 18 days F 2.7 Single ventricle, Pulm atresia 4 20
6 16 days M 3.1 Dextrocardia, Pulm atresia 3.5 22
7 5 days M 2.2 Pulm atresia 3.5 16
8 6 days M 2.5 Pulm atresia 3.75 22
Results: The procedure was successful in all patients. 5 patients with pulmonary atresia
underwent Glenn shunt at age of 6 - 7 months and are growing well while 3 patients with
HLHS survived only for next 3 - 4 weeks only as next surgery (bilateral PA banding) could
not be done in them.
Conclusions: Ductal stenting is a feasible option for initial management of patients with
ductal dependant circulation till the patient is taken up for definitive surgery.
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Results Of Adenosine Vasoreactivity Testing In Pulmonary Hypertension By Basilar
And Radial Access
Luis Berumen Dominguez, Sr.
Hospital Militar, Mexico, Mexico
Background: Pulmonary Hypertension is a frequent disease in third level hospitals, with
elevated morbidity and mortality in short time. To choose the medical treatment is
fundamental to do a pulmonary vasoreactivity test.
Objective: To show and classify the results of the vasoreactivity test in the different
groups of pulmonary Hypertension, done by basilar and radial Access.
Material and Method: By consecutive simple we captured cases in which left and right
catheterism is done in patients with pulmonary hypertension, since November 2010 to
January 2012. By basilar access we did the right catheterism, oximetries and pressure are
registered, in superior vena cava, Inferior vena cava, Right Ventricle and Pulmonary
Trunk. By radial Access pressures and oximetries are registered in aorta and Left
Ventricle. Cardiac output is determined by Fick Method. The vasoreactivity was evaluated
with adenosine infusion in the pulmonary trunk, in doses of 100 mcg/kg/min with a
maximum of 12 mgs. A positive test is considered when Mean Pulmonary arterial pressure
(mPAP) decrease more than 10 mmHg or a (mPAP) less than 40 mmHg without
affection of the cardiac output.
Results: 92 procedures were done, 57% women, mean age 44 years, 58 patients of the group
1, 22 of the group 2, 7 of the group 3 and 5 of the group 4. Only 8% of the patients responded
to adenosine infusion, 6 patients from the group 1 and 1 patient from de group 3 (Pulmonary
Hypertension classification, Dana Point 2008). The mPAP decreased on average of 17
mmHg, and it was sustained in average 7.2 minutes. All procedures were done successfully and
same day discharge. Complications: 2 patients referred severe chest pain with the adenosine
infusion, but not persistent electrocardiographic abnormalities are founded. 10% of patients
presented pain in the Access site that was controlled with analgesics.
Conclusions: Basilar and radial Access was accepted in 100% percent of the patients, and
all are same day discharged. There were no major complications and the vasoreactivity test
was positive only in 8% of the patients, principally patients of the group 1.
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